Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Stelara Settlement Gives Amgen US Ustekinumab Entry Date
Agreement With Johnson & Johnson’s Janssen Offers Amgen 1 January 2025 Launch Date
May 24 2023
•
By
David Wallace
Amgen will be able to launch no later than 1 January 2025 • Source: Shutterstock
More from Biosimilars
More from Products